• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    8.25 Up 0.27(3.38%) Mar 27, 4:00PM EDT
    |After Hours : 8.25 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:7.98
    Open:8.00
    Bid:8.03 x 300
    Ask:8.90 x 2500
    1y Target Est:7.69
    Beta:1.27
    Next Earnings Date:24-Apr-15IMGN Earnings announcement
    Day's Range:7.94 - 8.27
    52wk Range:5.34 - 15.59
    Volume:1,045,857
    Avg Vol (3m):1,604,310
    Market Cap:710.38M
    P/E (ttm):N/A
    EPS (ttm):-0.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IMGNUp 3.38%710.38M
    PFEUp 1.08%211.63B
    RHHBYDown 0.23%N/A
    SGENUp 1.40%4.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.65
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback